Evaluating the efficacy and safety of a novel prophylactic nasal spray in the prevention of SARS-CoV-2 infection: A multi-centre, double blind, placebo-controlled, randomised trial.

Background The COVID-19 pandemic continues to devastate communities all over the world. The aim of this study was to evaluate the efficacy and safety of the test agent as a prophylaxis against SARS-CoV-2 infection in a population of high-risk healthcare workers. Methods The study was a multi-centre,...

Descripción completa

Detalles Bibliográficos
Autores principales: Balmforth, Damian, Swales, James A, Silpa, Laurence, Dunton, Alan, Davies, Kay E., Davies, Stephen G., Kamath, Archana, Gupta, Jayanti, Gupta, Sandeep, Masood, M.Abid, McKnight, Áine, Rees, Doug, Russell, Angela J., Jaggi, Manu, Uppal, Rakesh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier B.V. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9313533/
https://www.ncbi.nlm.nih.gov/pubmed/35952426
http://dx.doi.org/10.1016/j.jcv.2022.105248

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9313533/
https://www.ncbi.nlm.nih.gov/pubmed/35952426
http://dx.doi.org/10.1016/j.jcv.2022.105248

Ejemplares similares